Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,851 across all filing types
Latest filing 2024-05-13 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
北京市金杜(青岛)律师事务所关于盈康生命科技股份有限公司2023年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2023 Annual General Meeting (AGM) of Yingkang Life Technology Co., Ltd. It details the procedures of convening and holding the AGM, the qualifications of attendees, the voting procedures, and the voting results for various resolutions. The document does not contain financial statements or detailed financial performance data but focuses on the legality and validity of the AGM process and voting outcomes. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the results of shareholder votes at the AGM. The document length is sufficient and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the appropriate classification is DVA with high confidence.
2024-05-13 Chinese
关于变更2023年年度股东大会现场会议地点的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the change of the venue for the 2023 Annual General Meeting (AGM) of 盈康生命科技股份有限公司. It details the new location, the date and time of the meeting, voting procedures, agenda items to be discussed and voted on, and instructions for shareholders to participate either in person or via online voting. It also includes procedural details such as registration and proxy voting forms. The document does not contain the actual AGM materials or reports but is focused on logistical and procedural information about the AGM event itself. Therefore, it fits the category of AGM Information (AGM-R). The document length is about 5,458 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings.
2024-05-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement by 盈康生命科技股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, prices, total amount spent, and compliance with relevant regulations. The document is short (1325 characters) and focuses on the update of the share buyback activity rather than a full financial report or other types of filings. It explicitly states it is a progress announcement of the share repurchase plan, which fits the definition of a Transaction in Own Shares (POS) filing. There is no indication that this is a full financial report, regulatory certification, or other categories such as capital financing or management changes. Therefore, the correct classification is POS with high confidence.
2024-05-06 Chinese
北京市金杜(青岛)律师事务所关于盈康生命科技股份有限公司控股股东增持公司股份的法律意见书
Major Shareholding Notification Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the increase in shareholding by a controlling shareholder in a listed company. It details the legal qualifications of the shareholder, the specifics of the share increase, compliance with relevant securities laws and regulations, and disclosure obligations. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a shareholding transaction. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2024-04-30 Chinese
关于控股股东及其一致行动人持股比例变动超过1%的公告
Major Shareholding Notification Classification · 95% confidence The document is an official announcement regarding changes in shareholding proportions by the controlling shareholder and its concerted parties, specifically disclosing that their shareholding has changed by more than 1%. It includes detailed information about the shareholders, shareholding percentages before and after the change, methods of share acquisition, and compliance with relevant securities laws and regulations. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about major shareholding changes, fitting the category of Major Shareholding Notification (MRQ). The document length is 3573 characters, which is typical for such announcements and not a full report or certification. Therefore, the correct classification is MRQ with high confidence.
2024-04-30 Chinese
关于控股股东增持公司股份计划的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the controlling shareholder's plan to increase their shareholding in the company. It details the shareholder's identity, current holdings, the amount and method of share purchase, and related regulatory compliance. There are no financial statements, earnings data, or management discussion of results. The document is a formal disclosure of a shareholding increase plan, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on this notification, not a report or earnings release.
2024-04-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.